Promising Pharmaceutical Stocks To Keep An Eye On - July 28th

Key Points

• Eli Lilly, Thermo Fisher Scientific, Merck & Co., and other companies are currently highlighted as top pharmaceutical stocks to watch, benefiting from exposure to the healthcare sector's growth potential.
• Eli Lilly's stock is currently trading at $810.62, with a market cap of $768.26 billion and a PE ratio of 66.03, reflecting its strong position in the market.
• Thermo Fisher Scientific, which provides life sciences solutions and analytical instruments, saw its stock rise to $485.62, with a market cap of $183.32 billion and a PE ratio of 28.11.

Eli Lilly and Company, Thermo Fisher Scientific, Merck & Co., Inc., Albemarle, Honeywell International, D-Wave Quantum, and AstraZeneca are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies engaged in the research, development, manufacture, and marketing of medications and medical therapies. Investors in these stocks gain exposure to the healthcare sector’s potential for growth driven by innovation, regulatory approvals, and patent lifecycles. Because drug pipelines and approval processes can be unpredictable, pharmaceutical stocks often exhibit higher volatility compared to more diversified industries. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE:LLY traded down $2.07 during trading hours on Monday, hitting $810.62. The company's stock had a trading volume of 1,383,269 shares, compared to its average volume of 3,751,170. The business's 50-day moving average is $771.95 and its two-hundred day moving average is $800.61. The company has a market capitalization of $768.26 billion, a PE ratio of 66.03, a PEG ratio of 1.18 and a beta of 0.40. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37. Eli Lilly and Company has a 52-week low of $677.09 and a 52-week high of $972.53.

Read Our Latest Research Report on LLY

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

NYSE:TMO traded up $7.30 during trading hours on Monday, hitting $485.62. The company's stock had a trading volume of 1,832,546 shares, compared to its average volume of 2,506,901. The business's 50-day moving average is $413.76 and its two-hundred day moving average is $469.17. The company has a market capitalization of $183.32 billion, a PE ratio of 28.11, a PEG ratio of 2.56 and a beta of 0.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.50 and a current ratio of 1.93. Thermo Fisher Scientific has a 52-week low of $385.46 and a 52-week high of $627.88.

Read Our Latest Research Report on TMO

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

NYSE:MRK traded down $0.14 during trading hours on Monday, hitting $84.57. The company's stock had a trading volume of 6,578,161 shares, compared to its average volume of 15,775,043. The business's 50-day moving average is $80.03 and its two-hundred day moving average is $85.10. The company has a market capitalization of $212.35 billion, a PE ratio of 12.31, a PEG ratio of 0.87 and a beta of 0.39. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.41. Merck & Co., Inc. has a 52-week low of $73.31 and a 52-week high of $127.99.

Read Our Latest Research Report on MRK

Albemarle (ALB)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

NYSE:ALB traded down $8.95 during trading hours on Monday, hitting $74.79. The company's stock had a trading volume of 6,966,634 shares, compared to its average volume of 3,371,183. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.26 and a current ratio of 2.11. The company has a market capitalization of $8.80 billion, a PE ratio of -6.72 and a beta of 1.63. Albemarle has a 52-week low of $49.43 and a 52-week high of $113.91. The business's 50-day moving average is $64.81 and its two-hundred day moving average is $69.65.

Read Our Latest Research Report on ALB

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company's Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

Honeywell International stock traded up $1.53 during trading hours on Monday, hitting $225.77. The stock had a trading volume of 2,130,827 shares, compared to its average volume of 4,135,443. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.29 and a quick ratio of 0.97. The stock has a market capitalization of $145.10 billion, a price-to-earnings ratio of 25.67, a PEG ratio of 2.52 and a beta of 1.07. Honeywell International has a 1-year low of $179.36 and a 1-year high of $242.77. The stock's fifty day moving average is $229.41 and its two-hundred day moving average is $216.94.

Read Our Latest Research Report on HON

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

D-Wave Quantum stock traded down $0.92 during trading hours on Monday, hitting $17.95. The stock had a trading volume of 23,762,215 shares, compared to its average volume of 70,931,008. The company has a debt-to-equity ratio of 0.15, a current ratio of 20.73 and a quick ratio of 20.61. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of -29.99 and a beta of 1.40. D-Wave Quantum has a 1-year low of $0.75 and a 1-year high of $20.56. The stock's fifty day moving average is $16.62 and its two-hundred day moving average is $10.35.

Read Our Latest Research Report on QBTS

AstraZeneca (AZN)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.

AstraZeneca stock traded down $0.79 during trading hours on Monday, hitting $71.88. The stock had a trading volume of 5,725,124 shares, compared to its average volume of 5,257,991. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.90 and a quick ratio of 0.70. The stock has a market capitalization of $222.91 billion, a price-to-earnings ratio of 28.88, a PEG ratio of 1.34 and a beta of 0.37. AstraZeneca has a 1-year low of $61.24 and a 1-year high of $87.68. The stock's fifty day moving average is $71.15 and its two-hundred day moving average is $71.17.

Read Our Latest Research Report on AZN

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.